Zobrazeno 1 - 10
of 2 488
pro vyhledávání: '"Lerebours F"'
Autor:
Espanol, A., Lerebours, F., Calviere, L., Bonneville, F., Ducros, A., Larrue, V., Gollion, C.
Publikováno v:
In Revue Neurologique June 2024 180(6):486-493
Autor:
Báez-Vallecillo, L., Ibrahim, N.K.
Publikováno v:
Breast Diseases: A Year Book Quarterly; 2015, Vol. 26 Issue 4, p317-319, 3p
Autor:
Dano, D., Lardy-Cleaud, A., Monneur, A., Quenel-Tueux, N., Levy, C., Mouret-Reynier, M.-A., Coudert, B., Mailliez, A., Ferrero, J.-M., Guiu, S., Campone, M., de La Motte Rouge, T., Petit, T., Pistilli, B., Dalenc, F., Simon, G., Lerebours, F., Chabaud, S., Bertucci, F., Gonçalves, A.
Publikováno v:
In ESMO Open August 2021 6(4)
Autor:
Lerebours, F., Vacher, S., Guinebretiere, J.M., Rondeau, S., Caly, M., Gentien, D., Van Laere, S., Bertucci, F., de la Grange, P., Bièche, l., Liang, X., Callens, C.
Publikováno v:
In Journal of Advanced Research February 2021 28:77-85
Autor:
Cloet F; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Gueyraud G; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Lerebours F; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Munio M; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Larrue V; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Gollion C; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; ToNIC, Toulouse NeuroImaging Center, University of Toulouse III, Inserm, France.
Publikováno v:
Cephalalgia : an international journal of headache [Cephalalgia] 2024 Nov; Vol. 44 (11), pp. 3331024241282015.
Autor:
Bertucci F; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France. bertuccif@ipc.unicancer.fr.; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France. bertuccif@ipc.unicancer.fr., Guille A; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France., Lerebours F; Department of Medical Oncology, Institut Curie Saint-Cloud, Paris, France., Ceccarelli M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.; Department of Public Health Sciences, University of Miami, Miami, USA., Syed N; University of Hawai'i Cancer Center, Honolulu, HI, USA., Adélaïde J; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France., Finetti P; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France., Ueno NT; University of Hawai'i Cancer Center, Honolulu, HI, USA., Van Laere S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium., Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France., De Nonneville A; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France., Goncalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France., Birnbaum D; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France., Callens C; Department of Medical Oncology, Institut Curie Saint-Cloud, Paris, France., Bedognetti D; Tumor Biology and Immunology Laboratory, Research Branch, Sidra Medicine, Doha, Qatar., Mamessier E; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, 232, Boulevard de Sainte-Marguerite, 13009, Marseille, France.
Publikováno v:
Journal of translational medicine [J Transl Med] 2024 Oct 27; Vol. 22 (1), pp. 969. Date of Electronic Publication: 2024 Oct 27.
Autor:
Seban RD; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France. romain.seban@gmail.com.; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France. romain.seban@gmail.com., Champion L; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France.; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France., De Moura A; Department of Medical Oncology, Institut Curie, 92210, Saint-Cloud, France., Lerebours F; Department of Medical Oncology, Institut Curie, 92210, Saint-Cloud, France., Loirat D; Department of Medical Oncology, Institut Curie, 75005, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Université Paris Cité, 75005, Paris, France.; Circulating Tumor Biomarkers Laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France., Djerroudi L; Department of Pathology, Institut Curie, 75005, Paris, France., Genevee T; Department of Pharmacy, Institut Curie, 92210, Saint-Cloud, France., Huchet V; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France., Jehanno N; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclay University, 92210, Saint-Cloud, France.; Circulating Tumor Biomarkers Laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France., Buvat I; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.
Autor:
Pagliuca M; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italia., Havas J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Thomas E; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Drouet Y; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Soldato D; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Franzoi MA; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Ribeiro J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Chiodi CK; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Pistilli B; Medical Oncology Department, INSERM U981, Gustave Roussy, Villejuif, France., Menvielle G; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Joly F; Clinical Research Depatment, Inserm U1086 Anticipe, Centre Francois Baclesse, University UniCaen, Caen, France., Lerebours F; Medical Oncology Department, Institut Curie Saint Cloud, Saint Cloud, France., Rigal O; Medical Oncology Department, Centre Henri Becquerel, Rouen, France., Petit T; Medical Oncology Department, Institute of Cancer Strasbourg (ICANS), Strasbourg, France., Giacchetti S; Department of Breast Disease, APHP, University Hospital Saint Louis, Senopole, Paris, France., Dalenc F; Medical Oncology Department, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France., Wassermann J; Medical Oncology Department, Pitié Salpêtrière University Hospital, Cancer University Institute, AP-HP, Paris, France., Arsene O; Medical Oncology Department, Centre Hospitalier de Blois, Blois, France., Martin AL; Direction des Data et des Partenariats, UNICANCER, Paris, France., Everhard S; Direction des Data et des Partenariats, UNICANCER, Paris, France., Tredan O; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Boyault S; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., De Laurentiis M; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italia., Viari A; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Deleuze JF; Centre National de Recherche en Génomique Humaine CNRGH-CEA, Laboratory of Excellence in Medical Genomics, GENMED, Évry-Courcouronnes, France., Bertaut A; Unit of Methodology and Biostatistics, George-François Leclerc Cancer Center, Dijon, France., André F; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Vaz-Luis I; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.
Autor:
Soldato D; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Michiels S; INSERM U1018 CESP, Service de Biostatistique et d'Epidemiologie, Institut Gustave Roussy, Villejuif, France., Havas J; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Di Meglio A; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Pagliuca M; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Franzoi MA; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Pistilli B; Medical Oncology Department, Gustave Roussy, Villejuif, France., Iyengar NM; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Cottu P; Institut Curie, Paris, France., Lerebours F; Institut Curie Saint Cloud, Saint Cloud, France., Coutant C; Centre Leon Berard, Lyon, France., Bertaut A; Centre Leon Berard, Lyon, France., Tredan O; Centre Georges-Francois Leclerc, Dijon, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Jouannaud C; Institut de Cancérologie Jean Godinot, Reims, France., Hrab I; Centre François Baclesse, Caen, France., Everhard S; UNICANCER, Paris, France., Martin AL; UNICANCER, Paris, France., André F; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Medical Oncology Department, Gustave Roussy, Villejuif, France., Vaz-Luis I; INSERM U981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Supportive Care and Pathways Department (DIOPP), Gustave Roussy, Villejuif, France., Jones LW; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 01; Vol. 42 (25), pp. 3022-3032. Date of Electronic Publication: 2024 Jun 05.
Autor:
Porte, B., Carton, M., Lerebours, F., Brain, E., Loirat, D., Haroun, L., Bellesoeur, A., Bach Hamba, S., Kirova, Y., Cottu, P.
Publikováno v:
In The Breast December 2020 54:303-310